logo

For the Inventor, By the Inventor

Birmingham, AL, United States of America

Dante J Marciani

USPTO Granted Patents = 16

Average Co-Inventor Count = 1.8

ph-index = 14

Forward Citations = 1,036(Granted Patents)


Location History:

  • Hopkinton, MA (US) (1988 - 1996)
  • Brimingham, AL (US) (2000)
  • Birmingham, AL (US) (1995 - 2007)

Company Filing History:

goldMedal6 out of 8 
 
Cambridge Biotech Corporation
 patents
silverMedal5 out of 5 
 
Galenica Pharmaceuticals, Inc.
 patents
bronzeMedal4 out of 6 
 
Cambridge Bioscience Corporation
 patents
4. 1 out of 1 
 
Adjuvantys, Inc.
 patent

Years Active: 1988-2007

Loading Chart...
16 patents (USPTO):Explore Patents
1. 7196073 - Imine-forming polysaccharide adjuvants and immunostimulants (2007-03-27),
2. 6960344 - Use of imine-forming polysaccharides as adjuvants and immunostimulants (2005-11-01),
3. 6573245 - Modified polysaccharide adjuvant-protein antigen conjugates, the preparation thereof and the use thereof (2003-06-03),
4. 6262029 - Chemically modified saponins and the use thereof as adjuvants (2001-07-17),
5. 6080725 - Immunostimulating and vaccine compositions employing saponin analog (2000-06-27),
6. 5977081 - Triterpene saponin analogs having adjuvant and immunostimulatory activity (1999-11-02),
7. 5650398 - Drug delivery enhancement via modified saponins (1997-07-22),
8. 5583112 - Saponin-antigen conjugates and the use thereof (1996-12-10),
9. 5443829 - Modified saponins isolated from Quillaja saponaria (1995-08-22),
10. 5352449 - Vaccine comprising recombinant feline leukemia antigen and saponin (1994-10-04),
11. 5273965 - Methods for enhancing drug delivery with modified saponins (1993-12-28),
12. 5231003 - Monoclonal antibodies specific for Toxin B of Clostridium difficile (1993-07-27),
13. 5057540 - Saponin adjuvant (1991-10-15),
14. 4921787 - Detection of antibodies to human immunodeficiency virus by agglutination (1990-05-01),
15. 4753873 - Peptides for the diagnosis of HTLV-III antibodies, their preparation and (1988-06-28),

Title: The Innovative Mind of Dante J. Marciani

Introduction

Dante J. Marciani is an accomplished inventor based in Birmingham, AL, who has made significant contributions to the field of immunology. With a remarkable portfolio of 16 patents, he has been at the forefront of developing innovative solutions that enhance the effectiveness of vaccines and therapeutic agents.

Latest Patents

Marciani's recent patents include groundbreaking inventions concerning imine-forming polysaccharide adjuvants and immunostimulants. These inventions elaborate on polysaccharide conjugates designed to bind to surface receptors on Antigen Presenting Cells. By covalently attaching stable carbonyl compounds, either directly or through bifunctional linkers, these conjugates serve as immuno-stimulants and adjuvants, helping to optimize the immune response in various applications.

Career Highlights

Dante Marciani has built an impressive career, working with notable companies such as Cambridge Biotech Corporation and Galenica Pharmaceuticals, Inc. His work in these organizations has focused on advancing biotechnological approaches to improve health outcomes through innovative product development.

Collaborations

Throughout his career, Marciani has collaborated with esteemed professionals, including Charlotte A. Kensil and Sean Soltysik. These partnerships have fostered a conducive environment for creativity and innovation, facilitating the development of effective immunostimulants and adjuvants.

Conclusion

Dante J. Marciani's innovative spirit and commitment to advancing science have cemented his status as a prominent inventor in the field of immunology. His contributions, particularly through his latest patents, continue to influence research and application in vaccine technology, showcasing the vital role of inventors in addressing global health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…